← Eichor
Condition: Recurrent Thymoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Thymoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06301945PT-112 in Subjects With Thymoma and Thymic Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05104736First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Art
Phase 2 · 1 location(s) · National Cancer Center, Japan · NCT05832827A Study of KC1036 in Patients with Advanced Thymic Tumors
Phase 2 · 2 location(s) · Beijing Konruns Pharmaceutical Co., Ltd. · NCT05683886Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · 21 location(s) · Institut Curie · NCT04731610
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.